Details

Risk Classification of Good Pharmacovigilance Practices (GVP) Observations (GUI-0063) - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Feb 16, 2026 · edition #6
Timestamp: 2026-02-16T17:32:38.814Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/risk-classification-pharmacovigilance-observations-0063.html
Replay URL: https://replay.healtharchive.ca/job-6/20260216173238/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/risk-classification-pharmacovigilance-observations-0063.html#ha_snapshot=511458
ID: 511458
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots